Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024;23(8):1015-1029.
doi: 10.2174/0118715273270473231002104610.

Role of Astrogliosis in the Pathogenesis of Parkinson's Disease: Insights into Astrocytic Nrf2 Pathway as a Potential Therapeutic Target

Bharat Bhushan  1 , Niraj Kumar Singh  1
Affiliations
Review

Role of Astrogliosis in the Pathogenesis of Parkinson's Disease: Insights into Astrocytic Nrf2 Pathway as a Potential Therapeutic Target

Bharat Bhushan et al. CNS Neurol Disord Drug Targets. 2024.

Abstract

Recently, Parkinson's disease (PD) has become a remarkable burden on families and society with an acceleration of population aging having several pathological hallmarks such as dopaminergic neuronal loss of the substantia nigra pars compacta, α-synucleinopathy, neuroinflammation, autophagy, last but not the least astrogliosis. Astrocyte, star-shaped glial cells perform notable physiological functions in the brain through several molecular and cellular mechanisms including nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway. It has been well established that the downregulation of the astrocytic Nrf2 signaling pathway plays a crucial role in the pathogenesis of PD because it is a master regulator of cellular defense mechanism along with a regulator of numerous detoxifying and antioxidant enzymes gene expression. Fascinatingly, upregulation of the astrocytic Nrf2 signaling pathway attenuates the degeneration of nigrostriatal neurons, restores neuronal proliferation, rejuvenates astrocytic functions, and exhibits neuroprotective effects via numerous cellular and molecular mechanisms in the PD-like brain of the experimental animal. Here, we discuss the numerous in-vitro and in-vivo studies that evaluate the neuroprotective potential of the astrocytic Nrf2 signaling pathway against experimentally-induced PD-like manifestation. In conclusion, based on available preclinical reports, it can be assumed that the astrocytic Nrf2 signaling pathway could be an alternative target in the drug discovery process for the prevention, management, and treatment of PD.

Keywords: Nrf2; Parkinson’s disease; astrocyte; astrogliosis; neuroprotection.; α-synuclein.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Tolosa E.; Garrido A.; Scholz S.W.; Poewe W.; Challenges in the diagnosis of Parkinson’s disease. Lancet Neurol 2021,20(5),385-397 - DOI - PubMed
    1. Singh N.K.; Bhushan B.; Preclinical evidence-based neuroprotective potential of silibinin. Curr Drug Res Rev 2023
    1. Balestrino R.; Schapira A.H.V.; Parkinson disease. Eur J Neurol 2020,27(1),27-42 - DOI - PubMed
    1. Singh N.K.; Singh A.; Varshney M.; Agrawal R.; A research update on exendin-4 as a novel molecule against parkinson’s disease. Curr Mol Med 2023,2023,1566524023666230529093314 - DOI
    1. Perez F.A.; Palmiter R.D.; Parkin-deficient mice are not a robust model of parkinsonism. Proc Natl Acad Sci 2005,102(6),2174-2179 - DOI - PubMed

MeSH terms